Why is Marksans Pharma falling/rising?

As of 17-Sep, Marksans Pharma Ltd's stock price is currently at Rs 179.50, reflecting an increase of Rs 3.4, or 1.93%. The stock has shown a positive trend recently, gaining for the last three consecutive days with a total return of 3.76% during this period. It outperformed its sector by 1.89% today and reached an intraday high of Rs 180.5. However, despite these short-term gains, the stock has underperformed over the longer term, with a year-to-date decline of 39.41%. The company has a high management efficiency indicated by a return on equity (ROE) of 17.66% and a low debt-to-equity ratio, which may support investor confidence. Nonetheless, the company has reported poor long-term growth, with operating profit declining at an annual rate of -0.29% over the last five years, and recent financial results have shown significant declines in profit before tax and profit after tax compared to previous quarters.
In the broader market context, the stock's short-term performance aligns with the benchmark, as both the stock and the Sensex have returned +1.56% over the past week. However, the stock's year-to-date performance starkly contrasts with the Sensex's gain of 5.83%, highlighting its struggle to keep pace with the market. The stock's liquidity appears adequate for trading, but a notable decline in delivery volume suggests a potential decrease in investor interest. Overall, while recent price movements indicate a temporary rise, the underlying fundamentals and long-term performance metrics suggest caution for investors considering the stock.